Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
A study published in PMC on oxidative stress in Graves' disease found that: *Hyperthyroidism is associated with increased lipid peroxidation products in thyroid and liver tissue *Glutathione peroxidase activity is upregulated in an attempt to compensate for increased ROS generation - but this compensatory response is often insufficient, leading to net oxidative damage *Antioxidant treatment may help counter some of the clinical manifestations of thyrotoxicosis by reducing ROS-driven cellular damage A review in PMC on oxidative stress in Graves' disease concluded: "These data suggest that increased ROS generation may contribute to generate some clinical manifestations of thyrotoxicosis and that antioxidant treatment may be beneficial." Selenium supplementation - acting through GPx and the glutathione system - has been shown to delay disease progression and improve quality of life in patients with Graves' orbitopathy (the eye complication of Graves' disease), as confirmed by the Frontiers in Endocrinology review
This case report highlights the importance of considering appendicitis as a potential adverse effect of Tirzepatide, a GLP1/GIP receptor agonist
Shot Logging Capture injections with a clean, one-tap flow that keeps dose, site, and timing neatly organized
How does semaglutides weight loss benefit compare to other GLP-1 medications like Ozempic
Revisiting the 6-month BT-first recommendation Clinical practice guidelines have evolved towards a complications-centric approach to obesity management, yet outdated recommendations regarding intervention timing persist
